PNH is a rare, life-threatening disease of the blood characterised by destruction of red blood cells, blood clots and impaired bone marrow function, causing fatigue, recurrent infections and ...

PMID 30055352. Summary: This study by Amy DeZern, Robert Brodsky and Richard Jones explores whether eculizumab affects the success of bone marrow transplant in patients with severe aplastic anemia and ...

For months, doctors in Michigan had been searching for a bone marrow donor for a 68-year-old African American patient. She had been treated for acute myeloid leukemia once before, but the fast ...

If approved, crovalimab would be the first PNH drug that could be given by subcutaneous injection once a month outside a supervised healthcare setting, setting up a challenge to AstraZeneca's ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

PTP is characterized by the development of severe, sudden and self-limiting thrombocytopenia occurring 5-10 days after a blood transfusion. The recipients always have a history of sensitization ...

Nocturnal acid breakthrough is defined as the presence of intragastric pH < 4 during the overnight period for at least 60 continuous minutes in patients taking a proton-pump inhibitor (PPI ...

According to preliminary information provided by Ernst Jacques, these ammunitions came from the PNH stock and he obtained them with the complicity of his partner.

Bone marrow failure syndromes are rare diseases characterized by an inability to make enough blood – either red cells, which carry oxygen; white cells, which fight infection; or platelets, which help ...

The primary aim of the Cologne ExAfib Trial is to assess the feasibility and safety of different exercise modes in patients diagnosed with paroxysmal AF. Secondary outcomes include assessments of ...